A new study conducted at the University of Birmingham has revealed that women undergoing chemotherapy prior to surgery for advanced ovarian cancer had a reduced risk of complications and death within 28 days after surgery. In addition, study lead author Sean Kehoe, professor of gynecological cancer at the University of Birmingham, states that the trial showed that "shrinking the tumor with chemotherapy before surgery reduced side effects and hospital stay", thus improving a patient's quality of life.
To read more about this study, click here.
No comments:
Post a Comment